SNSE

Sensei Biotherapeutics, Inc.

• Seeking Alpha·1d ago

  Most and least shorted small-to-mid-cap stocks

• Seeking Alpha·4d ago

  Most and least shorted healthcare stocks with up to $2B market cap in March

• Reuters·6d ago

  Sensei Biotherapeutics publishes presentation on Faeth acquisition, $200 million private placement to advance PIKTOR

• Benzinga·03/30 11:50

  Sensei Biotherapeutics Q4 EPS $(3.74) Beats $(4.11) Estimate

• Seeking Alpha·03/30 11:37

  Sensei Biotherapeutics GAAP EPS of -$16.72

• TipRanks·03/30 11:36

  Sensei Biotherapeutics reports FY25 EPS ($16.72) vs ($24.01) last year

• Dow Jones·03/30 11:34

  *Sensei Biotherapeutics FY Loss/Shr $16.72 >SNSE

• Dow Jones·03/30 11:33

  *Sensei Biotherapeutics: Financing, Together With Cash on Hand, Expected to Support Advancement of PIKTOR Through Key Clinical Milestones >SNSE

• Dow Jones·03/30 11:33

  *Sensei Biotherapeutics: Cash Position: Cash, Cash Equivalents and Marketable Securities Were $21.2M as of Dec 31 >SNSE

• Dow Jones·03/30 11:32

  *Sensei Biotherapeutics Report Fincl Results for Full Yr, Following Previously Announced Acquisition of Faeth Therapeutics and Concurrent $200M Private Placement >SNSE

• Reuters·03/30 11:30

  SENSEI BIOTHERAPEUTICS REPORTS FULL YEAR 2025 FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE

• Dow Jones·03/30 11:30

  Press Release: Sensei Biotherapeutics Reports -2-

• Dow Jones·03/30 11:30

  Press Release: Sensei Biotherapeutics Reports Full Year 2025 Financial Results and Provides Corporate Update

• Reuters·03/17 10:00

  Sensei Biotherapeutics grants employee stock option for 166,435 shares at USD 29.37

• Reuters·03/17 10:00

  SENSEI BIOTHERAPEUTICS ANNOUNCES INDUCEMENT GRANTS UNDER NASDAQ LISTING RULE 5635(C)(4)